Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasms × PTC596 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Leiomyosarcoma 2 Ovarian Neoplasms 1 Neoplasms 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

pembrolizumab 154 Gemcitabine 142 Paclitaxel 132 Carboplatin 118 Bevacizumab 112 Cyclophosphamide 99 Docetaxel 97 Cisplatin 97 Exercise 80 Nivolumab 79 Capecitabine 78 Fluorouracil 76 Dexamethasone 73 Irinotecan 66 Oxaliplatin 61 Radiotherapy 59 Pemetrexed 59 Standard of Care 56 Leucovorin 55 Cetuximab 49 Drug Therapy 47 Blood Specimen Collection 47 Sorafenib 45 Erlotinib Hydrochloride 44 Doxorubicin 44 atezolizumab 40 130-nm albumin-bound paclitaxel 38 trametinib 37 fludarabine 35 Methods 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02404480 2017-12-08

PTC596 in Patients With Advanced Solid Tumors

PTC Therapeutics

Phase 1 Completed

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡